![Yves Ribeill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yves Ribeill
Directeur Général chez
Ribogenics, Inc.
Profil
Yves Joseph Ribeill is the founder of SCYNEXIS, Inc., founded in 1999, where the title held was Director from 2015 to 2016.
Current jobs include Chief Executive Officer at Enodia Therapeutics, President & Chief Executive Officer at Ribogenics, Inc., President & Chief Executive Officer at COREzonada, Inc. since 2017, and Director at Ogeda SA. Former jobs include Executive Chairman at Calyxt, Inc. in 2021, Director at Synergia Medical SA, Principal at Rhone-Poulenc Rorer, Inc., and Principal at Aventis Pharma SA in 2000.
Education includes a doctorate from Université de Montpellier.
Postes actifs de Yves Ribeill
| Sociétés | Poste | Début |
|---|---|---|
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Directeur/Membre du Conseil | 28/08/2009 |
COREzonada, Inc.
 COREzonada, Inc. BiotechnologyHealth Technology Operates as a biotechnology company working on microbiome re-engineering | Directeur Général | 01/08/2017 |
Ribogenics, Inc.
 Ribogenics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | - |
Anciens postes connus de Yves Ribeill
| Sociétés | Poste | Fin |
|---|---|---|
| SCYNEXIS, INC. | Fondateur | 16/03/2016 |
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/01/2000 |
Synergia Medical SA
 Synergia Medical SA Packaged SoftwareTechnology Services Develops optoelectronics for neurostimulation medical devices | Directeur/Membre du Conseil | - |
Calyxt, Inc.
 Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Directeur Général | 01/10/2018 |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Corporate Officer/Principal | - |
Formation de Yves Ribeill
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Université de Montpellier
 Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Commercial Services |
Synergia Medical SA
Synergia Medical SA Packaged SoftwareTechnology Services Develops optoelectronics for neurostimulation medical devices | Technology Services |
Ribogenics, Inc.
Ribogenics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
COREzonada, Inc.
COREzonada, Inc. BiotechnologyHealth Technology Operates as a biotechnology company working on microbiome re-engineering | Health Technology |
